Prevymis 240 mg/12 mL (20 mg/mL) injection Images
Generic Name: letermovir
This medication has been identified as Prevymis 240 mg/12 mL (20 mg/mL) injection. It is supplied by Merck.
Prevymis is used in the treatment of CMV Prophylaxis and belongs to the drug class miscellaneous antivirals. Prevymis 240 mg/12 mL (20 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Prevymis
- Generic Name
- letermovir
- Strength
- 240 mg/12 mL (20 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antivirals
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck
- National Drug Code (NDC)
- 00006-5003
More about Prevymis (letermovir)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español
Patient resources
- Prevymis drug information
- Prevymis (Letermovir Intravenous) (Advanced Reading)
- Prevymis (Letermovir Oral) (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
